Zai Lab Limited (ZLAB)
USD 29.03
(19.37%)
USD 29.03
(19.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 170.9 Million USD | 21.19% |
| 2022 | 141.02 Million USD | 53.16% |
| 2021 | 92.07 Million USD | 185.75% |
| 2020 | 32.22 Million USD | 248.88% |
| 2019 | 9.23 Million USD | 10656.73% |
| 2018 | 85.86 Thousand USD | 115.66% |
| 2017 | -548.12 Thousand USD | -175.43% |
| 2016 | -199 Thousand USD | -57.31% |
| 2015 | -126.5 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 65.27 Million USD | 21.93% |
| 2024 Q1 | 53.53 Million USD | 31.87% |
| 2023 Q4 | 40.59 Million USD | -7.21% |
| 2023 Q1 | 41.46 Million USD | -0.52% |
| 2023 Q2 | 45.1 Million USD | 8.78% |
| 2023 Q3 | 43.74 Million USD | -3.0% |
| 2023 FY | 170.9 Million USD | 21.19% |
| 2022 Q3 | 37.49 Million USD | 21.86% |
| 2022 Q1 | 31.08 Million USD | 38.34% |
| 2022 FY | 141.02 Million USD | 53.16% |
| 2022 Q4 | 41.67 Million USD | 11.15% |
| 2022 Q2 | 30.76 Million USD | -1.0% |
| 2021 Q2 | 26.06 Million USD | 106.91% |
| 2021 Q4 | 22.46 Million USD | -27.39% |
| 2021 Q1 | 12.59 Million USD | 52.3% |
| 2021 FY | 92.07 Million USD | 185.75% |
| 2021 Q3 | 30.94 Million USD | 18.7% |
| 2020 Q2 | 8.09 Million USD | 32.03% |
| 2020 Q3 | 9.71 Million USD | 19.98% |
| 2020 FY | 32.22 Million USD | 248.88% |
| 2020 Q1 | 6.13 Million USD | 99.81% |
| 2020 Q4 | 8.27 Million USD | -14.87% |
| 2019 Q1 | 1.26 Million USD | 1377.95% |
| 2019 FY | 9.23 Million USD | 10656.73% |
| 2019 Q4 | 3.06 Million USD | -15.37% |
| 2019 Q3 | 3.62 Million USD | 185.86% |
| 2019 Q2 | 1.26 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | 85.86 Thousand USD | 115.66% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | 85.86 Thousand USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | -548.12 Thousand USD | -175.43% |
| 2016 FY | -199 Thousand USD | -57.31% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 FY | -126.5 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -77.59 Million USD | 320.242% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1379.42% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 3661.963% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 34836.382% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -33085.049% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 276.28% |
| Agenus Inc. | 139.61 Million USD | -22.41% |
| Fortress Biotech, Inc. | 57.85 Million USD | -195.409% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 119361.554% |
| Novavax, Inc. | 639.93 Million USD | 73.294% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 25838.404% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -711.467% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 4729.009% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -486.711% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -41.859% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 88.741% |
| AlloVir, Inc. | -398 Thousand USD | 43040.452% |
| Aptorum Group Limited | -1.11 Million USD | 15431.914% |
| Ardelyx, Inc. | 106.66 Million USD | -60.23% |
| Bicycle Therapeutics plc | -129.52 Million USD | 231.951% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -142319.167% |
| Chimerix, Inc. | 324 Thousand USD | -52647.84% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 648.334% |
| CRISPR Therapeutics AG | 240.95 Million USD | 29.073% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2071.3% |
| Precision BioSciences, Inc. | 40.47 Million USD | -322.275% |
| Dyadic International, Inc. | 922.95 Thousand USD | -18416.897% |
| Elevation Oncology, Inc. | -39 Thousand USD | 438312.821% |
| Fortress Biotech, Inc. | 57.85 Million USD | -195.409% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 87.568% |
| Immix Biopharma, Inc. | -5468.00 USD | 3125612.07% |
| Innoviva, Inc. | 261.06 Million USD | 34.536% |
| IO Biotech, Inc. | -756 Thousand USD | 22706.217% |
| Jaguar Health, Inc. | 7.72 Million USD | -2112.623% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -42.713% |
| ContextLogic Inc. | 59 Million USD | -189.666% |
| AbCellera Biologics Inc. | 38.02 Million USD | -349.449% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 97846.55% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 310832.727% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 29.008% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 32529.412% |
| MEI Pharma, Inc. | 49.32 Million USD | -246.469% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -21209.601% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -488.205% |
| NextCure, Inc. | -3.68 Million USD | 4739.061% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -930.965% |
| ChromaDex Corporation | 50.78 Million USD | -236.556% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 261.042% |
| Incyte Corporation | 3.44 Billion USD | 95.033% |
| Opthea Limited | 21.72 Thousand USD | -786746.225% |
| MiMedx Group, Inc. | 266.84 Million USD | 35.954% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 386863.375% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -693.237% |
| Psyence Biomedical Ltd. | -240.00 USD | 71209683.333% |
| Vaxcyte, Inc. | -75 Million USD | 327.871% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 298224.76% |
| Pharming Group N.V. | 220.1 Million USD | 22.354% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -16837.859% |
| Onconetix, Inc. | -1.12 Million USD | 15262.199% |
| Acelyrin, Inc. | -115 Thousand USD | 148711.304% |
| PureTech Health plc | -1.6 Million USD | 10761.447% |
| Pyxis Oncology, Inc. | -2 Million USD | 8645.15% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 194.209% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 33172.922% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 144332.895% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -55.689% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -797.458% |
| Seer, Inc. | 7.02 Million USD | -2332.091% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 477.061% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 877.291% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1700458.173% |
| Summit Therapeutics Inc. | -2.05 Million USD | 8436.732% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 30030.473% |
| Senti Biosciences, Inc. | -2.68 Million USD | 6469.847% |
| ImmuCell Corporation | 4.39 Million USD | -3787.442% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 274.006% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 464.873% |
| Precigen, Inc. | 106 Thousand USD | -161129.245% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 3418160.0% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 689.972% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -4118.785% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -26.343% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 4435.386% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -481.56% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -3803.677% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -34356.25% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -40207.311% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 208518.293% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -64.174% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 274.101% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 73765.086% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -27962.89% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 45.515% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -6539.588% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 336921.048% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2507.763% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 36114.077% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1643398.077% |
| Soligenix, Inc. | 97.31 Thousand USD | -175525.572% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1681.118% |
| Kura Oncology, Inc. | -849 Thousand USD | 20229.918% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 354.684% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 116360.544% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -72.561% |
| Autolus Therapeutics plc | -4.86 Million USD | 3611.465% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -312.949% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 101827.976% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -80.424% |
| GRI Bio, Inc. | 10.84 Million USD | -1476.451% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -6628.502% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2067.342% |
| IGM Biosciences, Inc. | -211.66 Million USD | 180.744% |
| INmune Bio, Inc. | 155 Thousand USD | -110160.0% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -175.921% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 11445.948% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 26455.455% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 583904.741% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -42413.184% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 8662.275% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 54701.597% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -80.924% |
| Verastem, Inc. | -62 Thousand USD | 275750.0% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -6918.604% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 65580.077% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -5545.953% |
| Histogen Inc. | 3.76 Million USD | -4434.439% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -29561.442% |
| Surrozen, Inc. | -27.23 Million USD | 727.628% |
| Organovo Holdings, Inc. | -5.38 Million USD | 3271.33% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 14284.234% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 766.366% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -752.299% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 8631564.646% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2717.196% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 254681.341% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -10.409% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -117117.421% |
| Apollomics, Inc. | 127 Thousand USD | -134469.291% |
| Amarin Corporation plc | 165.54 Million USD | -3.239% |
| Mesoblast Limited | -9.81 Million USD | 1841.243% |
| Turnstone Biologics Corp. | 16.5 Million USD | -935.399% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 254.679% |
| Synaptogenix, Inc. | -6347.00 USD | 2692757.949% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 335203.922% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -5.911% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 90.277% |
| Better Therapeutics, Inc. | -2.72 Million USD | 6362.477% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 252.373% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 49.449% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1498197.826% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2830.08% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 15524.458% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -2235.378% |
| Insmed Incorporated | 239.63 Million USD | 28.682% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -4676.495% |
| OmniAb, Inc. | 14.66 Million USD | -1065.221% |
| Alector, Inc. | -95.05 Million USD | 279.798% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -36.047% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 493.215% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -108.731% |
| Aura Biosciences, Inc. | -1.29 Million USD | 13297.143% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -131363.846% |
| Immunic, Inc. | -111 Thousand USD | 154066.667% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -977.98% |
| Veracyte, Inc. | 248.14 Million USD | 31.129% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 102.445% |
| FibroGen, Inc. | 128.9 Million USD | -32.582% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 30302050.355% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1564.855% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 94.971% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -43833.933% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 51.905% |
| TG Therapeutics, Inc. | 219.1 Million USD | 22.001% |
| Galecto, Inc. | -830 Thousand USD | 20690.723% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 12439.567% |
| Fortrea Holdings Inc. | 424 Million USD | 59.693% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 298.339% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 30241.623% |
| XBiotech Inc. | -1.74 Million USD | 9899.484% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 15524.458% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 467.763% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 326.26% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -132.828% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -917.098% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 56.071% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 444.236% |
| Vaxxinity, Inc. | -2.23 Million USD | 7750.09% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 47.696% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1609.232% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -598.961% |
| NexImmune, Inc. | -1.02 Million USD | 16773.919% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -3164770.37% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2505.169% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.488% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 255839.447% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 4912.813% |
| Ainos, Inc. | -253.73 Thousand USD | 67455.448% |
| Pluri Inc. | 322 Thousand USD | -52975.466% |
| Prothena Corporation plc | -129.2 Million USD | 232.277% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -238.932% |
| Celularity Inc. | 6.75 Million USD | -2430.022% |
| Rallybio Corporation | -150 Thousand USD | 114035.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 624.13% |
| MeiraGTx Holdings plc | 287 Thousand USD | -59448.084% |
| Omeros Corporation | -69.77 Million USD | 344.92% |
| Humacyte, Inc. | -76.55 Million USD | 323.257% |
| Immunocore Holdings plc | 248.39 Million USD | 31.196% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1226.66% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -173.962% |
| Blueprint Medicines Corporation | 236.58 Million USD | 27.762% |
| CalciMedica, Inc. | -58 Thousand USD | 294760.345% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 12084.783% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 6109.248% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 653.711% |
| Pulmatrix, Inc. | -8.22 Million USD | 2179.112% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 14707.094% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 42932.832% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 142.855% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -6057.369% |
| Cytokinetics, Incorporated | -322.59 Million USD | 152.978% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -19723.919% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 50218.182% |
| Vor Biopharma Inc. | -3.49 Million USD | 4994.129% |
| Roivant Sciences Ltd. | 109.23 Million USD | -56.454% |
| Evogene Ltd. | 1.39 Million USD | -12116.083% |
| ProKidney Corp. | -3.16 Million USD | 5492.963% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 489.194% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -2392.387% |
| CorMedix Inc. | -205.56 Thousand USD | 83239.393% |
| BioLineRx Ltd. | 1.1 Million USD | -15324.458% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 317.238% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 517987.879% |
| Atai Life Sciences N.V. | -5000.00 USD | 3418160.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 140346.514% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 178123.958% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 12404.032% |
| Sagimet Biosciences Inc. | 2 Million USD | -8445.15% |
| MediciNova, Inc. | 979.7 Thousand USD | -17344.333% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 302.686% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 180844.54% |
| GeoVax Labs, Inc. | -20.72 Million USD | 924.791% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 30.111% |
| Biomea Fusion, Inc. | -4.2 Million USD | 4168.15% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 80.409% |
| Mereo BioPharma Group plc | 7.42 Million USD | -2201.414% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 55230.0% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1424291.667% |
| Absci Corporation | -41.84 Million USD | 508.38% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 3418160.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 323.774% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 7044.453% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 20.04% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 18261.849% |
| Allakos Inc. | -6.14 Million USD | 2882.983% |
| Imunon, Inc. | -720 Thousand USD | 23836.363% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 347.7% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 64.088% |
| BioAtla, Inc. | -103.73 Million USD | 264.756% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1498197.826% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 96112.921% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 170.383% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 55052.733% |
| XOMA Corporation | 3.86 Million USD | -4326.392% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 343.851% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1055.218% |
| aTyr Pharma, Inc. | -2.38 Million USD | 7256.742% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1271.613% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 589420.69% |
| Viridian Therapeutics, Inc. | -1 Million USD | 17054.663% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1314638361.538% |
| Akari Therapeutics, Plc | -4000.00 USD | 4272675.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 73.166% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -87674.0% |
| UroGen Pharma Ltd. | 73.35 Million USD | -132.99% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 740.23% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1471932.73% |
| Orgenesis Inc. | -5.72 Million USD | 3085.205% |
| Entera Bio Ltd. | -56 Thousand USD | 305283.929% |
| GH Research PLC | -315 Thousand USD | 54354.921% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 90524.868% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 32652.952% |
| Xencor, Inc. | -85.26 Million USD | 300.449% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 77439.723% |
| Replimune Group, Inc. | -2.65 Million USD | 6537.024% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 17169.202% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 3.903% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -87674.0% |
| Portage Biotech Inc. | -54 Thousand USD | 316587.037% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 180844.54% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 45432.361% |
| OncoCyte Corporation | 413 Thousand USD | -41280.872% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3802168.966% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 76983433.333% |
| Purple Biotech Ltd. | -196 Thousand USD | 87295.408% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1805.698% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1647.117% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1736.225% |
| HilleVax, Inc. | -2.15 Million USD | 8026.855% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 176288.66% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1139149.587% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 25684.281% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 743156.522% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 2276936.625% |
| Savara Inc. | -44.26 Million USD | 486.117% |
| Curis, Inc. | 9.81 Million USD | -1641.953% |
| Daré Bioscience, Inc. | 2.76 Million USD | -6070.848% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 137054.675% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 9984.5% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 75057.456% |
| BeiGene, Ltd. | 2.07 Billion USD | 91.779% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 6212.629% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 142.762% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -201.48% |
| Erasca, Inc. | -3.73 Million USD | 4679.394% |
| bluebird bio, Inc. | -4.03 Million USD | 4340.769% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 605752.42% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 91.026% |
| DBV Technologies S.A. | 15.72 Million USD | -986.616% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 605752.42% |
| Moderna, Inc. | 2.15 Billion USD | 92.069% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 18777.923% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2034.686% |
| Molecular Templates, Inc. | 50.39 Million USD | -239.127% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 31984.888% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -27.742% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2846.753% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 534.392% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 253.789% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 4863.183% |
| MacroGenics, Inc. | 50.52 Million USD | -238.241% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2902.607% |
| Prime Medicine, Inc. | -147.9 Million USD | 215.549% |
| Aditxt, Inc. | -111.66 Thousand USD | 153156.6% |
| Adagene Inc. | 18.11 Million USD | -843.616% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -34921.107% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -21.898% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -8.279% |
| SciSparc Ltd. | 2.19 Million USD | -7682.468% |
| Vericel Corporation | 135.57 Million USD | -26.057% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 682374.742% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 551720.296% |
| Generation Bio Co. | -73.91 Million USD | 331.228% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 39208.238% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -212.9% |
| Invivyd, Inc. | -2.02 Million USD | 8527.17% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 156.808% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 165322.645% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -77.344% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -73.88% |
| ADMA Biologics, Inc. | 88.21 Million USD | -93.728% |
| Clene Inc. | 533 Thousand USD | -31964.353% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -608.871% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 17958.203% |
| GeoVax Labs, Inc. | -20.72 Million USD | 924.791% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -8496.73% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 88051.069% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -243.144% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 2509.8% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 20542.943% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -104.883% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -233655.061% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -221.476% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 198.681% |
| Trevena, Inc. | 1.45 Million USD | -11645.911% |
| Surrozen, Inc. | -27.23 Million USD | 727.628% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 48514.448% |
| Cingulate Inc. | -582.91 Thousand USD | 29418.532% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 551400.0% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 967.572% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 2257735.403% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 19498.751% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 74.893% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 17397.874% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 303431.44% |
| Kronos Bio, Inc. | 1.37 Million USD | -12356.487% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 418.457% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 58628.425% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 35098.587% |
| ImmunityBio, Inc. | -17.89 Million USD | 1055.299% |
| Korro Bio, Inc. | -3.63 Million USD | 4808.072% |
| Kineta, Inc. | 5.43 Million USD | -3045.647% |
| BioVie Inc. | -229.37 Thousand USD | 74607.47% |
| Codexis, Inc. | 57.33 Million USD | -198.083% |
| Celularity Inc. | 6.75 Million USD | -2430.022% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -4158.734% |
| Celcuity Inc. | -142.77 Thousand USD | 119803.443% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -337719.727% |
| Cibus, Inc. | 1.42 Million USD | -11918.495% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 45795.989% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 845.683% |
| IN8bio, Inc. | -2.5 Million USD | 6933.387% |
| Kodiak Sciences Inc. | -25.94 Million USD | 758.662% |
| Annexon, Inc. | -3.26 Million USD | 5331.191% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 8461.204% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 509.476% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -26603.594% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 78.048% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 1.186% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 9094.895% |
| Arcellx, Inc. | 108.27 Million USD | -57.836% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 627.984% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -115.776% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 907.976% |
| Moolec Science SA | -143.3 Thousand USD | 119358.225% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 503.854% |
| Geron Corporation | -123.5 Million USD | 238.38% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -5099.361% |
| Royalty Pharma plc | 1.79 Billion USD | 90.473% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 343.834% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 4731633.776% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -73758.966% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 253.395% |
| Humacyte, Inc. | -76.55 Million USD | 323.257% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 18105.445% |
| 89bio, Inc. | -273 Thousand USD | 62701.832% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 13696.102% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 20253.656% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 139045.528% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -15172.833% |
| Notable Labs, Ltd. | 113 Thousand USD | -151141.593% |
| Liquidia Corporation | 14.6 Million USD | -1070.568% |
| Mustang Bio, Inc. | -2.22 Million USD | 7781.034% |
| Immunovant, Inc. | -231 Thousand USD | 74083.983% |
| Quantum-Si incorporated | 488 Thousand USD | -34921.107% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 407.606% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 569776.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -9078.464% |
| Acasti Pharma Inc. | -11 Thousand USD | 1553763.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 83623.363% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 26455.455% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 202.024% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -14963.107% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 44956.43% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 8828.447% |
| PepGen Inc. | -1.18 Million USD | 14534.375% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 134669.291% |
| United Therapeutics Corporation | 2.07 Billion USD | 91.744% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 846.399% |
| Solid Biosciences Inc. | -76.56 Million USD | 323.219% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 207046.95% |
| Immuneering Corporation | -764.13 Thousand USD | 22465.463% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -257812.29% |
| Belite Bio, Inc | -399 Thousand USD | 42932.832% |
| XOMA Corporation | 3.86 Million USD | -4326.392% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 952.98% |
| Bionomics Limited | -434.44 Thousand USD | 39437.874% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 16012.756% |
| uniQure N.V. | 2.21 Million USD | -7615.711% |
| Cassava Sciences, Inc. | -89.42 Million USD | 291.117% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 285.625% |
| Forte Biosciences, Inc. | -9000.00 USD | 1899022.222% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 20567.425% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 39208.238% |
| Altimmune, Inc. | -65.37 Million USD | 361.428% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 52.793% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 16012.756% |
| Compugen Ltd. | 31.45 Million USD | -443.325% |
| Peak Bio, Inc. | 367.76 Thousand USD | -46370.203% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -597.108% |
| Benitec Biopharma Inc. | 108 Thousand USD | -158143.519% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 219206.41% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 14306.401% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 9479.967% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 143715.966% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 14306.401% |
| Instil Bio, Inc. | -4.75 Million USD | 3693.419% |
| argenx SE | 1.1 Billion USD | 84.582% |
| Immunome, Inc. | -8.9 Million USD | 2018.749% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 9142.487% |
| Verona Pharma plc | -679.62 Thousand USD | 25246.699% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 97758.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 7265.744% |
| CervoMed Inc. | -1.29 Million USD | 13311.15% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 7200.249% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 3677.622% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -6816.35% |
| Moolec Science SA | -143.3 Thousand USD | 119358.225% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 41984.91% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 6497.2% |
| AnaptysBio, Inc. | 14.78 Million USD | -1056.234% |
| Design Therapeutics, Inc. | -537 Thousand USD | 31925.512% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 40124.122% |
| NeurAxis, Inc. | 2.15 Million USD | -7824.268% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -7863.793% |
| Lumos Pharma, Inc. | 2 Million USD | -8415.346% |
| Achilles Therapeutics plc | -4.73 Million USD | 3712.204% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 97758.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 161825.101% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -439.829% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -19723.919% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 16660.368% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 475.215% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -397348.837% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 20891.119% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1298952.409% |
| Palisade Bio, Inc. | 246 Thousand USD | -69372.764% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 517987.879% |
| Beam Therapeutics Inc. | -59.67 Million USD | 386.404% |
| Neurogene Inc. | -3.26 Million USD | 5339.209% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -22.656% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -327.258% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 57643.098% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 4343.889% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1886.567% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1113.8% |
| Athira Pharma, Inc. | -969 Thousand USD | 17737.049% |
| Vaccinex, Inc. | -16 Million USD | 1167.877% |
| HCW Biologics Inc. | -574.82 Thousand USD | 29831.361% |
| XOMA Corporation | 3.86 Million USD | -4326.392% |
| Nektar Therapeutics | 53.47 Million USD | -219.576% |
| Arvinas, Inc. | 71.8 Million USD | -138.026% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 304.77% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 372.247% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 53175.466% |
| Rezolute, Inc. | -36 Thousand USD | 474830.556% |
| Clene Inc. | 533 Thousand USD | -31964.353% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 13310302.492% |
| BeyondSpring Inc. | 1.75 Million USD | -9660.308% |
| Synlogic, Inc. | -1.92 Million USD | 8982.692% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 462000.0% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2799.037% |
| Peak Bio, Inc. | 367.76 Thousand USD | -46370.203% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1001.245% |
| Krystal Biotech, Inc. | 47.6 Million USD | -259.002% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -21.13% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -3301.055% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 6700.562% |
| MannKind Corporation | 136.19 Million USD | -25.488% |
| Ikena Oncology, Inc. | -50.49 Million USD | 438.475% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -57.06% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3997.446% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 67918.651% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 3418160.0% |
| Legend Biotech Corporation | 140.92 Million USD | -21.269% |
| Mural Oncology plc | -2.56 Million USD | 6757.694% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 31116.878% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 171003.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -723.47% |
| REGENXBIO Inc. | 53.02 Million USD | -222.282% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 3290.302% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 88938.467% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 9967.379% |
| Vaxart, Inc. | -60.76 Million USD | 381.262% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 65136.532% |
| Cellectis S.A. | 18 Thousand USD | -949361.111% |
| Longeveron Inc. | 221 Thousand USD | -77231.674% |
| Repare Therapeutics Inc. | -80.07 Million USD | 313.442% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 84.364% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 13307.342% |
| Revolution Medicines, Inc. | -399.66 Million USD | 142.762% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 488394.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -348681.633% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.014% |
| Denali Therapeutics Inc. | -93.34 Million USD | 283.087% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 682374.742% |
| Veru Inc. | 7.56 Million USD | -2158.85% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 113280.795% |
| Cingulate Inc. | -582.91 Thousand USD | 29418.532% |
| Passage Bio, Inc. | -3.72 Million USD | 4692.932% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1419088.708% |
| Exicure, Inc. | -1.42 Million USD | 12110.049% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 44722.193% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -6222.716% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 33435.544% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -150.863% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 114334.628% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 388.658% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -43609.207% |
| OmniAb, Inc. | 14.66 Million USD | -1065.221% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -754.814% |
| Lipocine Inc. | -2.85 Million USD | 6094.876% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 9373.087% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 3095.67% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 11445.948% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -126.915% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 263027.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -102.742% |
| Ocugen, Inc. | -33.53 Million USD | 609.595% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 5504.902% |
| Q32 Bio Inc. | 578 Thousand USD | -29467.993% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 64591.698% |
| Alumis Inc. Common Stock | -1.28 Million USD | 13410.202% |
| Equillium, Inc. | 35.95 Million USD | -375.285% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 10111.892% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -34034.246% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 4134183.212% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 66085.714% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -40330.127% |
| Dominari Holdings Inc. | 2.03 Million USD | -8281.707% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 93249.871% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1357.102% |
| Bio-Techne Corporation | 773.07 Million USD | 77.893% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -886.795% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 62.911% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 14719.589% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 812.69% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1361.084% |
| Nkarta, Inc. | -5.86 Million USD | 3011.961% |
| BioCardia, Inc. | -7.24 Million USD | 2457.608% |
| Iterum Therapeutics plc | -1.75 Million USD | 9865.886% |